Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper

BCR-ABL1 kinase domain (KD) mutation status is considered to be an important element of clinical decision algorithms for chronic myeloid leukemia (CML) patients who do not achieve an optimal response to tyrosine kinase inhibitors (TKIs). Conventional Sanger sequencing is the method currently recomme...

Descripción completa

Detalles Bibliográficos
Autores principales: Soverini, Simona, Abruzzese, Elisabetta, Bocchia, Monica, Bonifacio, Massimiliano, Galimberti, Sara, Gozzini, Antonella, Iurlo, Alessandra, Luciano, Luigiana, Pregno, Patrizia, Rosti, Gianantonio, Saglio, Giuseppe, Stagno, Fabio, Tiribelli, Mario, Vigneri, Paolo, Barosi, Giovanni, Breccia, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894351/
https://www.ncbi.nlm.nih.gov/pubmed/31801582
http://dx.doi.org/10.1186/s13045-019-0815-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894351/
https://www.ncbi.nlm.nih.gov/pubmed/31801582
http://dx.doi.org/10.1186/s13045-019-0815-5

Ejemplares similares